KOHJIN BIO CO LTD (177A.T)
JPY 1703.0
(-0.12%)
JPY 1703.0
(-0.12%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.46 Billion JPY | 17.6% |
| 2022 | 2.1 Billion JPY | -5.77% |
| 2021 | 2.22 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 FY | 2.46 Billion JPY | 17.6% |
| 2023 Q4 | 2.46 Billion JPY | 11.5% |
| 2023 Q3 | 2.21 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 33.241% |
| Linical Co., Ltd. | 3 Billion JPY | 17.729% |
| Trans Genic Inc. | 2.25 Billion JPY | -9.421% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -106952.232% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 0.084% |
| AnGes, Inc. | 362.67 Million JPY | -580.966% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -2211.388% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 96.661% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | -946.561% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | -122.713% |
| Carna Biosciences, Inc. | 182.97 Million JPY | -1249.774% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | -179.023% |
| RaQualia Pharma Inc. | 367.71 Million JPY | -571.627% |
| Chiome Bioscience Inc. | 291 Million JPY | -748.692% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 4.09% |
| PeptiDream Inc. | 22.79 Billion JPY | 89.168% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | -683.607% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | -271.383% |
| Healios K.K. | 4.53 Billion JPY | 45.505% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -2095.284% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -1628.837% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -2431.93% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | -164.62% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | -155.134% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | -241.151% |
| StemCell Institute Inc. | 8.78 Million JPY | -28015.836% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -1532.856% |